SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection

Mol Immunol. 2021 Jul:135:421-425. doi: 10.1016/j.molimm.2021.03.021. Epub 2021 Mar 26.

Author

Stefanos A Tsiftsoglou¹

Affiliation

¹ Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece. Electronic address: stefanos.tsiftsoglou@gmail.com.

No abstract available

Publication types

Letter
Review

MeSH terms

COVID-19* / genetics
COVID-19* / immunology
Complement Pathway, Alternative / genetics*
Complement System Proteins* / genetics
Complement System Proteins* / immunology
Genetic Variation*
Humans
SARS-CoV-2 / immunology*

Substances

Complement System Proteins